Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina
dc.contributor.authorPastre, Martin
dc.contributor.authorOccéan, Bob-Valéry
dc.contributor.authorBoudousq, Vincent
dc.contributor.authorConejero, Ismael
dc.contributor.authorFabbro-Peray, Pascale
dc.contributor.authorCollombier, Laurent
dc.contributor.authorMallet, Luc
dc.contributor.authorLópez Castromán, Jorge
dc.date.accessioned2026-03-16T09:51:27Z
dc.date.available2026-03-16T09:51:27Z
dc.date.issued2024-11-07
dc.date.updated2025-12-04T09:36:11Z
dc.description.abstractObsessive-compulsive disorder (OCD) is a frequent and disabling condition, with many patients being treatment-resistant. Improved understanding of its neurobiology is vital for better therapies. Evidence is still conflicting regarding specific serotonergic-related dysfunctions in OCD. We systematically reviewed the literature to provide a quantitative assessment of the role of serotonin (5-HT) in patients with untreated OCD through imaging. We searched for neuroimaging studies investigating central 5-HT tonus in unmedicated patients with OCD, excluding studies comprising treated patients to prevent bias from antidepressant-induced changes in serotonergic tonus. We also conducted a meta-analysis using a homogeneous group of positron emission tomography and single photon emission computed tomography articles that compared 5-HT transporter (SERT) and 5-HT2A receptor (HT2AR) binding potential in different brain regions of patients with untreated OCD and healthy controls. The systematic review encompassed 18 articles, with 13 included in the subsequent meta-analysis. Risk of bias was assessed by a revised form of the Newcastle-Ottawa Scale. We provided standardized mean difference (SMD) values for SERT and 5-HT2AR binding potential measures across 15 different brain regions. Patients with OCD showed lower SERT binding potential in the brainstem (SMD = −1.13, 95% CI [−1.81 to −0.46]), midbrain (SMD = −0.54, 95% CI [−0.92 to −0.16]), and thalamus/hypothalamus regions (SMD = −0.58, 95% CI [−0.99 to −0.18]) with neglectable to moderate heterogeneity. By combining results from 2 decades of molecular imaging studies, we show that individuals with OCD exhibit lower SERT binding potential in specific brain regions, providing compelling evidence of a 5-HT system dysfunction. However, the exact mechanisms underlying this phenotype remain elusive. The limitations include heterogeneity across studies in populations, imaging techniques, and radiotracer usage.en
dc.identifier.citationPastre, M., Occéan, B.-V., Boudousq, V., Conejero, I., Fabbro-Peray, P., Collombier, L., Mallet, L. and Lopez-Castroman, J. (2025), Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings. Psychiatry Clin. Neurosci., 79: 48-59. https://doi.org/10.1111/pcn.13760
dc.identifier.doi10.1111/pcn.13760
dc.identifier.eissn1440-1819
dc.identifier.essn1440-1819
dc.identifier.urihttps://hdl.handle.net/10347/46392
dc.journal.titlePsychiatry and Clinical Neurosciences
dc.language.isoeng
dc.publisherWiley
dc.relation.publisherversionhttps://doi.org/10.1111/pcn.13760
dc.rights© 2024 The Author(s). Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject5-HT2A binding
dc.subjectMolecular imaging
dc.subjectObsessions
dc.subjectSerotonin
dc.subjectSERT binding
dc.titleSerotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findingsen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
oaire.funderIdentifier10.13039/501100013327
oaire.funderIdentifier10.13039/100007054
oaire.funderNameFrench Ministry of Health
oaire.funderNameH. Lundbeck A/S
oaire.funderNameMeso Scale Diagnostics
oaire.funderNameFrench Institute of Research in Public Health
relation.isAuthorOfPublicationf7a5397c-2347-44b2-9c2b-c6c52eca56d6
relation.isAuthorOfPublication.latestForDiscoveryf7a5397c-2347-44b2-9c2b-c6c52eca56d6

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024_pcn_lopez-castroman_serotonergic.pdf
Size:
352.06 KB
Format:
Adobe Portable Document Format